News Oligomerix to Present at Clinical Trials on Alzheimer’s Disease Conference & Life Sciences Summit October 29, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousAlzheimer’s biotech firm moves HQ to White Plains Crain’s New York Business Health PulseNext →Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains
